Pfizer beats profit estimates on cost cuts, COVID vaccine sales
(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine. "Our revenue volatility is largely in the past as COVID-related uncertainties have diminished,
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's nomination moved forward.
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.
Pfizer shows profit growth from cost cuts and steadier COVID sales
By Bhanvi Satija, Michael Erman (Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings related to its COVID-19 vaccine.
Pfizer gets unexpected boost from Covid vaccine and pill
Sales of the Covid vaccine and pill were around $550 million more than analysts had been expecting for the quarter. Pfizer investors are trying to figure out what the “new normal” will be for those products as interest in treating the virus fades with time.
Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
McKnight's Long-Term Care News3h
‘Vaccine fatigue’ could be a common LTC theme in 2025
Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.
Is a 'quademic' swirling? What you should know about flu, RSV, COVID and norovirus
RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
Trump's reinstatement of troops booted over COVID vaccine hailed as win for freedom: 'Great day for patriots'
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
Time on MSN7d
RFK Jr. Says He Doesn’t Know if COVID-19 Vaccines Work
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...
Executive Council blocks contract over vaccine policy
The Executive Council blocked a $25,000 contract until Dartmouth Health proved to state prosecutors that it's complying with the Patient Bill of Rights and not denying treatment based on someone's ...
Unity, lost: Five years after COVID, we’re more divided than ever
After a brief moment when Americans came together to battle a virus, the pandemic accelerated divisions of all kinds. If it ...
verywellhealth2d
Flu, COVID, and RSV: It's Peak Season
For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...
Hosted on MSN3d
Nanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other Coronaviruses
A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...